Literature DB >> 15502208

DNA isolation and sample preparation for quantification of adduct levels by accelerator mass spectrometry.

Karen H Dingley1, Esther A Ubick, John S Vogel, Kurt W Haack.   

Abstract

A protocol is described for the isolation of DNA and subsequent preparation of samples for the measurement of adduct levels by accelerator mass spectrometry (AMS). AMS is a highly sensitive technique used for the quantification of adducts following exposure to carbon-14- or tritium-labeled chemicals, with detection limits in the range of one adduct per 10(11)-10(12) nucleotides. However, special precautions must be taken to avoid cross-contamination of isotope between samples and to produce a sample that is compatible with AMS. The DNA isolation method described is based on digestion of tissue with proteinase K, followed by extraction of DNA using Qiagen DNA isolation columns. DNA is then precipitated with isopropanol, washed repeatedly with 70% ethanol to remove salt, and then dissolved in water. This method has been used to generate reliably good yields of uncontaminated, pure DNA from animal and human tissues for analysis of adduct levels. For quantification of adduct levels from 14C-labeled compounds, DNA samples are then converted to graphite, and the 14C content is measured by AMS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15502208     DOI: 10.1385/1-59259-840-4:021

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  8 in total

Review 1.  Accelerator mass spectrometry-enabled studies: current status and future prospects.

Authors:  Ali Arjomand
Journal:  Bioanalysis       Date:  2010-03       Impact factor: 2.681

2.  Measurement of 7,8-dihydro-8-oxo-2'-deoxyguanosine metabolism in MCF-7 cells at low concentrations using accelerator mass spectrometry.

Authors:  Sang Soo Hah; Janna M Mundt; Hyung M Kim; Rhoda A Sumbad; Kenneth W Turteltaub; Paul T Henderson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-25       Impact factor: 11.205

Review 3.  Recent technical and biological development in the analysis of biomarker N-deoxyguanosine-C8-4-aminobiphenyl.

Authors:  Zhidan Chen; Yuesheng Zhang; Paul Vouros
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2018-04-24       Impact factor: 3.205

Review 4.  Quantifying exploratory low dose compounds in humans with AMS.

Authors:  Stephen R Dueker; Le T Vuong; Peter N Lohstroh; Jason A Giacomo; John S Vogel
Journal:  Adv Drug Deliv Rev       Date:  2010-10-31       Impact factor: 15.470

5.  Mouse lung CYP1A1 catalyzes the metabolic activation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).

Authors:  Xiaochao Ma; Jeffrey R Idle; Michael A Malfatti; Kristopher W Krausz; Daniel W Nebert; Chong-Sheng Chen; James S Felton; David J Waxman; Frank J Gonzalez
Journal:  Carcinogenesis       Date:  2006-10-19       Impact factor: 4.944

6.  Gemcitabine causes minimal modulation of carboplatin-DNA monoadduct formation and repair in bladder cancer cells.

Authors:  Sisi Wang; Hongyong Zhang; Michael Malfatti; Ralph de Vere White; Primo N Lara; Kenneth Turteltaub; Paul Henderson; Chong-xian Pan
Journal:  Chem Res Toxicol       Date:  2010-10-28       Impact factor: 3.739

7.  Detection of Adriamycin-DNA adducts by accelerator mass spectrometry at clinically relevant Adriamycin concentrations.

Authors:  Kate E Coldwell; Suzanne M Cutts; Ted J Ognibene; Paul T Henderson; Don R Phillips
Journal:  Nucleic Acids Res       Date:  2008-07-16       Impact factor: 16.971

8.  Assessment of different permeabilization methods of minimizing damage to the adherent cells for detection of intracellular RNA by flow cytometry.

Authors:  Zahra Amidzadeh; Abbas Behzad Behbahani; Nasrollah Erfani; Sedigheh Sharifzadeh; Reza Ranjbaran; Leili Moezi; Farzaneh Aboualizadeh; Mohammad Ali Okhovat; Parniyan Alavi; Negar Azarpira
Journal:  Avicenna J Med Biotechnol       Date:  2014-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.